TP53 and hepatocellular carcinoma: If HCC development was linked to vector integration, one would expect frequent integration sites to predominate over the episomal form particularly near known HCC oncogenes such as TP53 and NFE2L2. Furthermore, sequencing of the patient’s entire genome identified a deletion on chromosome 8, which is common in nearly 50% of HCC unrelated to gene therapy.